First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico
Toronto, Ontario--(Newsfile Corp. - February 27, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, announced today plans to further expand the leasing of its approximately 700-kilometre dark fiber optic network located in Central Mexico. The network represents the largest dark fiber infrastructure in the region, serving several of Mexico's most
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-02-27 8:30 AM EST | Akanda Corp
Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference
Toronto, Ontario--(Newsfile Corp. - February 25, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, is pleased to announce that it will participate at the upcoming TD Cowen 46th Annual Health Care Conference in Boston, MA. Members of management will present on March 4, 2026, at 10:30 a.m. EST.
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-02-25 7:27 AM EST | Cardiol Therapeutics Inc.
City View Investee Company ArkenYield Launches Arken Stablecoin Rating Standard and Reports 4.1% January Return from Stablecoin Market Making Operations
Toronto, Ontario--(Newsfile Corp. - February 12, 2026) - City View Green Holdings Inc. (CSE: CVGR) (OTCID: CVGRF) (FSE: CVY0) (the "Company" or "City View"), announces that its investee company ArkenYield, a builder of stablecoin liquidity and yield infrastructure, today announced the public release of its Arken Stablecoin Rating Framework, a standardized methodology created to evaluate the quality, stability, liquidity, and governance of USD stablecoins across on chain and exchange venues.
Food / Beverages, Cannabis, Cannabis Extractor, Cannabis Manufacturer
2026-02-12 6:30 AM EST | City View Green Holdings Inc.
Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
Toronto, Ontario--(Newsfile Corp. - February 10, 2026) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease, today announced the publication of results from its Phase II ARCHER study in ESC Heart Failure, a journal of the European Society of Cardiology. The peer-reviewed article reports resu
Biotechnology, Cannabis, Health, Cannabis Manufacturer
2026-02-10 7:27 AM EST | Cardiol Therapeutics Inc.